atenolol has been researched along with Acute Disease in 24 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis." | 9.08 | Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol. ( Baron, B; Bernaud, C; Hotton, JM; Kahn, JC; Marchand, X; Pathé, M; Rocha, P; Zannier, D, 1997) |
| "The mortality in intracerebral hemorrhage (ICH) is mainly due to raised intracranial pressure, and its complications mediated by sympathetic overactivity." | 5.39 | Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage? ( Kalita, J; Kumar, B; Misra, UK, 2013) |
| "Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects." | 5.32 | Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003) |
| "The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis." | 5.08 | Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol. ( Baron, B; Bernaud, C; Hotton, JM; Kahn, JC; Marchand, X; Pathé, M; Rocha, P; Zannier, D, 1997) |
| " She had received atenolol for hypertension for 3 years prior to surgery and it was reintroduced at a dose of 100 mg/day because of recurrence of hypertension." | 3.75 | Atenolol hepatotoxicity: report of a complicated case. ( Boillot, O; Dumortier, J; Gouraud, A; Guillaud, O; Pittau, G; Scoazec, JY; Vial, T, 2009) |
| "Pretreatment with atenolol did not change this pattern, although the changes in S-FFA and S-Mg were of a smaller magnitude but still statistically significant." | 2.66 | S-Mg does not change inversely to S-FFA during acute stress situations. ( Hansen, O; Johansson, BW, 1989) |
| "The mortality in intracerebral hemorrhage (ICH) is mainly due to raised intracranial pressure, and its complications mediated by sympathetic overactivity." | 1.39 | Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage? ( Kalita, J; Kumar, B; Misra, UK, 2013) |
| "Acute-on-chronic type B aortic dissection, complicated by aneurysmal dilatation of the thoracic aorta and visceral malperfusion." | 1.33 | Staged endovascular treatment for complicated type B aortic dissection. ( Amukotuwa, SA; McLachlan, CS; Mossop, PJ; Nixon, IK, 2005) |
| "Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects." | 1.32 | Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003) |
| "3." | 1.28 | Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated haemorrhage in awake rabbits. ( Evans, RG; Ludbrook, J; Potocnik, SJ, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumortier, J | 1 |
| Guillaud, O | 1 |
| Gouraud, A | 1 |
| Pittau, G | 1 |
| Vial, T | 1 |
| Boillot, O | 1 |
| Scoazec, JY | 1 |
| Machado, MP | 1 |
| Rocha, AM | 1 |
| de Oliveira, LF | 1 |
| de Cuba, MB | 1 |
| de Oliveira Loss, I | 1 |
| Castellano, LR | 1 |
| Silva, MV | 1 |
| Machado, JR | 1 |
| Nascentes, GA | 1 |
| Paiva, LH | 1 |
| Savino, W | 1 |
| Junior, VR | 1 |
| Brum, PC | 1 |
| Prado, VF | 1 |
| Prado, MA | 1 |
| Silva, EL | 1 |
| Montano, N | 1 |
| Ramirez, LE | 1 |
| Dias da Silva, VJ | 1 |
| Kalita, J | 1 |
| Misra, UK | 1 |
| Kumar, B | 1 |
| Cao, L | 1 |
| Hudson, CA | 1 |
| Lawrence, DA | 1 |
| Pedretti, RF | 1 |
| Prete, G | 1 |
| Foreman, RD | 1 |
| Adamson, PB | 1 |
| Vanoli, E | 1 |
| Mossop, PJ | 1 |
| McLachlan, CS | 1 |
| Amukotuwa, SA | 1 |
| Nixon, IK | 1 |
| Yusuf, S | 2 |
| Ramsdale, D | 1 |
| Peto, R | 1 |
| Furse, L | 1 |
| Bennett, D | 1 |
| Bray, C | 1 |
| Sleight, P | 2 |
| Groth, H | 1 |
| Foerster, EC | 1 |
| Neyses, L | 1 |
| Kulhmann, U | 1 |
| Vetter, H | 1 |
| Vetter, W | 1 |
| May, GS | 1 |
| DeMets, DL | 1 |
| Friedman, LM | 1 |
| Furberg, C | 1 |
| Passamani, E | 1 |
| Shalev, Y | 1 |
| Ben-Hur, H | 1 |
| Hagay, Z | 1 |
| Blickstein, I | 1 |
| Epstein, M | 1 |
| Ayzenberg, O | 1 |
| Gelven, A | 1 |
| Caspi, A | 1 |
| Rocha, P | 1 |
| Pathé, M | 1 |
| Bernaud, C | 1 |
| Zannier, D | 1 |
| Baron, B | 1 |
| Marchand, X | 1 |
| Hotton, JM | 1 |
| Kahn, JC | 1 |
| Nozawa, T | 1 |
| Inoue, H | 1 |
| Ichiyama, T | 1 |
| Sakai, T | 1 |
| Catania, A | 1 |
| Barsh, GS | 1 |
| Furukawa, S | 1 |
| Lipton, JM | 1 |
| Arora, P | 1 |
| Kumar, V | 1 |
| Dubey, NK | 1 |
| Mahesh, K | 1 |
| Galcerá-Tomás, J | 1 |
| Castillo-Soria, FJ | 1 |
| Villegas-García, MM | 1 |
| Florenciano-Sánchez, R | 1 |
| Sánchez-Villanueva, JG | 1 |
| de La Rosa, JA | 1 |
| Martínez-Caballero, A | 1 |
| Valentí-Aldeguer, JA | 1 |
| Jara-Pérez, P | 1 |
| Párraga-Ramírez, M | 1 |
| López-Martínez, I | 1 |
| Iñigo-García, L | 1 |
| Picó-Aracil, F | 1 |
| Schley, G | 1 |
| Beckmann, R | 1 |
| Hengstebeck, W | 1 |
| Lopez, R | 1 |
| Abendroth, RR | 1 |
| Hübner, H | 1 |
| Stephan, K | 1 |
| Meesmann, W | 1 |
| Hansen, O | 1 |
| Johansson, BW | 1 |
| Evans, RG | 1 |
| Ludbrook, J | 1 |
| Potocnik, SJ | 1 |
| Ibel, H | 1 |
| Zimmer, HG | 1 |
| Mousson, C | 1 |
| Justrabo, E | 1 |
| Tanter, Y | 1 |
| Chalopin, JM | 1 |
| Rifle, G | 1 |
| Niada, R | 1 |
| Porta, R | 1 |
| Pescador, R | 1 |
| Mantovani, M | 1 |
| Prino, G | 1 |
2 reviews available for atenolol and Acute Disease
| Article | Year |
|---|---|
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Huma | 1981 |
[Treatment with beta-blockers in patients with acute coronary syndrome].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Atenolol; Clinical Trials as Topic; Co | 1998 |
7 trials available for atenolol and Acute Disease
| Article | Year |
|---|---|
Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.
Topics: Acute Disease; Atenolol; Clinical Enzyme Tests; Clinical Trials as Topic; Electrocardiography; Femal | 1980 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Huma | 1981 |
Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol.
Topics: Acute Disease; Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Female; H | 1997 |
Effects of early use of atenolol or captopril on infarct size and ventricular volume: A double-blind comparison in patients with anterior acute myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Bloo | 2001 |
Anti-dysrhythmic treatment in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind | 1979 |
Effect of atenolol on recovery of the electrocardiographic signs of myocardial infarction.
Topics: Acute Disease; Aged; Atenolol; Clinical Trials as Topic; Electrocardiography; Follow-Up Studies; Hea | 1979 |
S-Mg does not change inversely to S-FFA during acute stress situations.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Atenolol; Epinephrine; Fatty Acids, Nonesterified | 1989 |
16 other studies available for atenolol and Acute Disease
| Article | Year |
|---|---|
Atenolol hepatotoxicity: report of a complicated case.
Topics: Acute Disease; Adrenergic beta-Antagonists; Atenolol; Chemical and Drug Induced Liver Injury; Female | 2009 |
Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease.
Topics: Acute Disease; Animals; Atenolol; Chagas Disease; Electrocardiography; Heart Rate; Inflammation; Mal | 2012 |
Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?
Topics: Acute Disease; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Antihypertens | 2013 |
Acute cold/restraint stress inhibits host resistance to Listeria monocytogenes via beta1-adrenergic receptors.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atenolol; Cold Temperature; Immunity, Innate; I | 2003 |
Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Dru | 2003 |
Staged endovascular treatment for complicated type B aortic dissection.
Topics: Acute Disease; Adult; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Atenolol; Back | 2005 |
[Nifedipine in hypertensive emergencies and severe hypertension].
Topics: Acute Disease; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Therapy, Combination; F | 1984 |
Successful delivery following myocardial ischemia during the second trimester of pregnancy.
Topics: Acute Disease; Adult; Atenolol; Cardiac Catheterization; Coronary Angiography; Female; Heparin; Huma | 1993 |
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Atenol | 1999 |
Nebulised salbutamol: an antidote for beta blockers.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Al | 1999 |
[The treatment of acute cardiac dysrhythmias with atenolol (Tenormin) particularly after myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Atenolol; Atrial Fibrillation; Atrial Flutter; Car | 1978 |
[Prevention of arrhythmias in acute myocardial infarct using the beta-sympatholytic ICI 66082].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Atenolol; Dogs; Myocardial Infarction; Propanolamines | 1976 |
Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated haemorrhage in awake rabbits.
Topics: Acute Disease; Animals; Atenolol; Central Nervous System; Cisterna Magna; Heart; Hemodynamics; Hemor | 1989 |
Metabolic recovery following temporary regional myocardial ischemia in the rat.
Topics: Acute Disease; Adenine Nucleotides; Adenosine Triphosphate; Animals; Atenolol; Coronary Disease; Fem | 1986 |
[Acute granulomatous interstitial nephritis and hepatitis caused by drugs. Possible role of an allopurinol-furosemide combination].
Topics: Acute Disease; Allopurinol; Atenolol; Biopsy; Chemical and Drug Induced Liver Injury; Female; Furose | 1986 |
Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Atenolol; Cats; Coronary Disease; Creatine Kinase; E | 1985 |